Perineural prolotherapy for chronic knee osteoarthritis pain
Official title: Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain: A Randomized Controlled Trial.
Run by National and Kapodistrian University of Athens · NCT07245121 · Data updated 2026-11-12
This trial will test whether adding 5% dextrose to perineural injections reduces pain in adults with chronic knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 38 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | National and Kapodistrian University of Athens Academic / other |
| Locations | 1 site (Athens, Attica) |
| Status | Recruiting |
| Started | November 24, 2025 |
| Main results expected | December 2026 |
| Study ends | February 2027 |
| Registry record updated | December 2, 2025 |
| Trial ID | NCT07245121 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults older than 38 with symptomatic knee osteoarthritis (Kellgren-Lawrence grade 2–3), persistent moderate–severe pain (NRS >5) for at least three months, and BMI up to 42 may be eligible.
✕Probably not a fit
Patients with very advanced osteoarthritis (KL grade 4), active knee infection, recent knee surgery, or lower pain levels are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center randomized controlled trial compares perineural prolotherapy using 5% dextrose plus local anesthetic versus local anesthetic alone, delivered to four genicular nerve sites around the knee. Ultrasound guidance is used to place injections at the superomedial, superolateral, inferomedial, and recurrent peroneal genicular nerves. Adults over 38 with chronic knee osteoarthritis, moderate to severe pain (NRS >5), and Kellgren-Lawrence grade 2–3 disease are eligible and randomized into two arms. Outcomes focus on pain reduction and function over follow-up to see if adding dextrose provides greater and possibly longer-lasting analgesia than anesthetic alone.
Why it matters
Potential benefit: If successful, adding dextrose could provide greater and longer-lasting pain relief and improved knee function without destroying nerve tissue.
How similar studies have gone: Perineural prolotherapy is a relatively new approach with some initial positive reports suggesting benefit, but larger randomized trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients of both sexes 2. Age \>38 years 3. Body Mass Index (BMI) up to 42 kg/m2 4. Diagnosis of knee osteoarthritis, according to the clinical criteria of the American College of Rheumatology. Osteoarthritis if the following combinations are present: A, B, C, D or A, B, E or A, D, E: A) Knee pain most days of the previous month B) Cracking during active joint movement C) Morning stiffness lasting at least 30 minutes D) Age at least 38 years E) Bone swelling of the affected knee on physical examination 5. Chronic knee pain on the Numerical Rating Scale (NRS) \> 5 for at least 3 months prior to the study 6. Grade 2 or 3 osteoarthritis, according to the Kellgern-Lawrence classification 7. Pain, creaking, and stiffness in the knee joint that persists for at least three months prior to the study. Exclusion Criteria: 1. Any infection of the skin of the knee joint, such as cellulitis, or periarticular or intraarticular infection during the last 3 months 2. Poorly controlled diabetes mellitus or connective tissue disease affecting the knee joint 3. History of previous total knee arthroplasty or other knee surgery. 4. History of periarticular or intraarticular injection of corticosteroids, local anesthetic, hyaluronic acid, platelet-rich plasma, radiofrequency, prolotherapy within the last trimester 5. History of knee injury or fracture within the last 3 months 6. History of acute lumbosacral radiculopathy or peripheral neuropathy, neurological, psychiatric disease 7. Pain limited in the posterior aspect of the knee 8. History of limb malignancy 9. History of bleeding disorder 10. Pregnancy 11. Allergy to local anesthetics, needle phobia 12. Difficulty communicating (severe hearing loss, dementia, language problems) 13. Non-guaranteed transportation to hospital for treatments and re-evaluations
Where it's running
-
University General Hospital of Athens "Attikon" - National and Kapodistrian University of Athens Medical School
Athens, Attica, Greece Recruiting
Study contacts
- Study coordinator: Konstantinos Kalimeris MD, PhD, Associate Professor of Anesthesiology, Associate Professor
- Email: kkalimeris@med.uoa.gr
- Phone: +302105831997
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Comparing two types of dextrose injections for knee osteoarthritis treatment
This study is testing whether a special type of knee injection guided by MRI works better than a standard injection for people aged 45 to 80 with knee osteoarthritis.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.